§ 13F · FUND PROFILE
Squadron Capital Management LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 37Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$68M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | RLMD | RELMADA THERAPEUTICS INC | 8.47M | $59M | 21.6% | +26% |
| 2 | COGT | COGENT BIOSCIENCES INC | 787K | $30M | 11.1% | +1% |
| 3 | KALV | KALVISTA PHARMACEUTICALS INC | 985K | $20M | 7.3% | +86% |
| 4 | KOD | KODIAK SCIENCES INC | 380K | $14M | 5.3% | +30% |
| 5 | ABVX | ABIVAX SA | 130K | $14M | 5.3% | −10% |
| 6 | EWTX | EDGEWISE THERAPEUTICS INC | 350K | $11M | 4.0% | ±0% |
| 7 | NKTR | NEKTAR THERAPEUTICS | 125K | $9M | 3.3% | NEW |
| 8 | ANL | ADLAI NORTYE LTD | 1.27M | $9M | 3.2% | NEW |
| 9 | ZNTL | ZENTALIS PHARMACEUTICALS INC | 3.63M | $8M | 3.1% | NEW |
| 10 | MAZE | MAZE THERAPEUTICS INC | 258K | $8M | 2.8% | −47% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE SQUADRON SIGNAL
AC read
Squadron Capital Management LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed